JAMA Submission Guide

The 2-day median desk decision tells you what the filter really looks like: editors reject most papers within 48 hours. If your title, abstract, and Key Points don't make the general-medicine case immediately, the paper never reaches a reviewer. That speed also means JAMA is faster than most top journals at letting you move on, NEJM's desk turnaround is similar, but The Lancet can take 1-2 weeks.

JAMA is published by the American Medical Association (AMA). Submission caps: Original Investigation ~3,000 words main text, 6 tables or figures, 50 references, per JAMA author guidelines.

Required-artifacts submission checklist for JAMA:

1. Main manuscript using JAMA template

1. Cover letter naming the practice-changing clinical or population-health consequence

1. Structured abstract (350-word limit, IMRaD-format)

1. Figures and tables (6 maximum) plus supplementary information / supplementary material as eAppendix

1. CONSORT, STROBE, PRISMA, or other reporting-checklist completion form

1. Ethics approval statement and patient-consent documentation (trial registration ID for any clinical trial)

1. Author contributions statement using CRediT taxonomy and conflicts of interest disclosure

1. Funding statement listing all grants and support sources

1. Data availability statement / data sharing statement plus ORCID IDs for all authors

1. Suggested reviewers list and editorial statistician availability confirmation

Week 1: Submission intake and editorial screen

The JAMA Network submission system verifies CONSORT/STROBE/PRISMA reporting-checklist completion, ethics approval, and trial registration ID. The handling editor then reads the cover letter and abstract to assess practice-relevance for a broad US clinical readership. About 60 to 70 percent of submissions are desk-rejected at this stage.

Week 2: Editorial discussion + JAMA Network routing

Borderline papers are discussed across the JAMA editorial team. Some receive transfer offers to JAMA Internal Medicine, JAMA Network Open (open-access), JAMA Cardiology, JAMA Oncology, or other JAMA Network specialty journals where reviewer reports can carry forward.

Weeks 3 to 4: Reviewer recruitment and statistical review assignment

For papers passing the editorial screen, 2 to 3 reviewers are recruited including at least one clinical-research methodologist. JAMA assigns dedicated statistical reviewers for clinical trial papers.

Weeks 5 to 8: External peer review

Reviewers evaluate clinical importance, methods rigor, generalizability to US clinical practice, and statistical analysis quality.

Weeks 8 to 10: Reviewer-report synthesis and decision

Handling editor integrates reports. Major-revision decisions specify the evidence gaps and broaden-the-audience asks that must close before resubmission.

JAMA is not a stronger version of a specialty journal. Editors are screening for four things simultaneously:

1. Clinical importance across medicine. The question must matter beyond one subspecialty. Interesting data without a broad practice consequence falls short.

1. Methodological discipline. Design quality, adequate sample size, follow-up strength, and generalizability all need to be visible on first read. A paper that sounds important but has visible analytical weaknesses will not survive initial statistical screening.

1. Package completeness. JAMA uses the submission package itself as a filter. The mandatory elements, structured abstract, Key Points (Question / Findings / Meaning in 75-100 words), Data Sharing Statement, and the matched EQUATOR checklist, are not just formatting. Weak Key Points or a vague Data Sharing Statement tell editors the manuscript is not ready for the general-medicine audience.

1. First-read clarity. Editors need to understand what changed and why it matters without digging through specialist framing. The title, abstract, and first figure or table should make the practice consequence obvious within 1-2 minutes.

Many technically solid papers fail because the work is good but the audience case is too narrow. If you removed the journal name, would the paper still feel like a general medical paper? If not, the fit problem is bigger than formatting.

Not every JAMA submission is an Original Investigation. Understanding which format fits your work prevents scope mismatch before you start.

Original Investigation is the primary research lane: 3,000 words, structured abstract, Key Points, up to 5 tables/figures, 50-75 references. This is where RCTs, large cohort studies, and definitive observational analyses land. The evidence bar is high, editors want studies that change practice, not just report associations.

Research Letter is shorter (600 words, 1 figure/table, 6 references) and suited for preliminary findings, novel observations, or replication studies that don't warrant full-length treatment. Research Letters still go through peer review, and they still need to matter to a general audience. Many authors underestimate this format's rigor.

Viewpoint (1,200 words, no abstract) allows opinion and analysis on topics relevant to medicine. It's invited or unsolicited, but unsolicited Viewpoints face steep competition. The argument needs to be timely, specific, and grounded in evidence, not a general commentary on a broad topic.

Review / Clinical Review articles are typically commissioned, but JAMA accepts proposals. These are comprehensive evidence syntheses aimed at clinicians who need an actionable summary. If your work would be better framed as a review, propose it explicitly rather than forcing it into the Original Investigation format.

JAMA operates within the JAMA Network, which includes 11 specialty journals (JAMA Cardiology, JAMA Oncology, JAMA Internal Medicine, JAMA Neurology, and others). This changes the submission calculus in two ways.

First, when JAMA's editors desk-reject a paper, they may offer a referral to the specialty journal they think fits better. Authors can also preselect referral during submission. This is not a consolation prize, JAMA Network specialty journals are well-ranked in their fields, and a referral can save months of resubmission time.

Second, this means your cover letter needs to anticipate the referral question. If your paper could plausibly go to JAMA Cardiology, explain in the letter why the general-medicine audience is the right one. If you can't make that case convincingly, the specialty journal might actually be the better strategic target.

The strongest JAMA cover letters sound like one editor helping another understand the paper. They should:

• define the clinical question in one sentence

• explain the practical or policy consequence in concrete terms

• argue why JAMA's general-medicine readership is the right audience, not why the journal is prestigious

• acknowledge the article type and explain why flagship JAMA (not a JAMA Network specialty journal) is the right venue

JAMA's instructions let authors preselect referral to a Network specialty journal if the flagship rejects. If the paper would obviously fit JAMA Oncology or JAMA Cardiology more naturally, the letter should not pretend otherwise. Editors notice when the cover letter is asking for prestige rather than audience fit.

Before submitting to JAMA, a JAMA manuscript fit check identifies whether the package meets the editorial bar before you commit to the submission.

Specialty paper dressed in broad language. If the paper mainly serves one subspecialty, no amount of general phrasing will change the fit. This is the single most common desk rejection reason.

Practical consequence is weak or overstated. Either the result doesn't change practice visibly enough, or the framing promises more than the evidence supports. JAMA editors are trained to spot both.

Key Points are vague. If the Question / Findings / Meaning summary doesn't make the practice change obvious, editors read that as the authors not yet knowing what the paper actually says.

Package looks operationally loose. Incomplete disclosures, soft checklist work, unstable Data Sharing Statements, or a structured abstract that reads like it was pasted in late. JAMA screens harder at the front door than most journals.

Design vulnerability is visible. Underpowered studies, too-local populations, or methodological gaps that the cover letter tries to explain away. Editors see those problems faster than authors expect.

Cross-document mismatches. JAMA requires manuscript word count on the title page, and the package has to be internally consistent across manuscript, checklist, protocol, and registry details. A trial registration that doesn't match the paper's primary endpoint, or a CONSORT flow diagram that conflicts with the methods section, gets noticed at the editorial stage. JAMA is one of the journals where cross-document inconsistency triggers rejection before scientific review begins.

Understanding the post-submission timeline helps set expectations and plan your response strategy.

Days 1-2 (editorial triage). Most JAMA submissions receive an initial editorial decision within 48 hours. The majority are desk rejections, often with a suggestion to consider a JAMA Network specialty journal. This is the fastest desk triage among the big four general medical journals.

Days 3-25 (peer review, if invited). Papers that pass the editorial screen go to 2-3 external reviewers. JAMA's median first decision with peer review is 25 days, faster than The Lancet or BMJ, comparable to NEJM. JAMA also uses dedicated statistical reviewers, which means your analytical approach will be examined by someone with specific biostatistical expertise.

Revision requests. If you receive a revise-and-resubmit, respond precisely. JAMA editors track whether revisions address every reviewer point. Do not introduce new analyses or findings not requested by reviewers, this resets the editorial clock and raises questions about the stability of the original work.

Days 43+ (acceptance to publication). Once accepted, the median time to online publication is 43 days. JAMA publishes accepted papers online before print, so your work becomes citable quickly.

• Is JAMA a Good Journal?

• How to Avoid Desk Rejection at JAMA

• JAMA Network Open submission guide

• JAMA citation metric

• Is BMJ a Good Journal?

Before you upload, run your manuscript through a JAMA submission readiness check to catch the issues editors filter for on first read.

Read the public instructions for mechanics, then pressure-test the package the way an editor will see it. The review tells you whether your paper clears the JAMA fit check before upload, especially around scope-fit ambiguity in the abstract, methods package incomplete for the journal's reviewer pool, and reference-list and clean-citation failure mode. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.

For JAMA-targeted manuscripts, three patterns consistently predict desk-screen failure at JAMA (Journal of the American Medical Association). The patterns below are the same ones the journal's handling editors and outside reviewers flag at first-pass triage.

Scope-fit ambiguity in the abstract

JAMA editors move fastest on manuscripts whose contribution is obviously aligned with clinical research with practice-relevant implications for US-based physicians. The named failure pattern: mechanism-only papers without clinical-application pathway get desk-rejected within 7 days. Check whether your abstract reads to JAMA's scope

For JAMA specifically, this failure is visible across the title, structured abstract, Key Points, first table, and cover letter. The manuscript may be scientifically strong, but if the title reads like a subspecialty endpoint, the abstract opens with disease-specific context, and the Key Points Meaning line never names a practice, policy, diagnostic, or public-health consequence, the package does not feel like flagship JAMA. The fix is not bigger language.

It is a tighter general-medicine argument that shows what changed, for whom, and why the finding should be read by clinicians outside the originating specialty.

Methods package incomplete for the journal's reviewer pool

JAMA reviewers expect specific methodological detail. Trials with pre-specified primary endpoint not matching the headline finding extend revision rounds. Check if your methods package is reviewer-complete

Check methods package incomplete for the journal's reviewer pool before submitting to JAMA →

This pattern usually appears in the methods section, protocol, trial registry, statistical analysis plan, CONSORT or STROBE checklist, and data sharing statement. JAMA's reviewer pool includes clinical experts and statistical reviewers, so small inconsistencies become visible quickly. If the registry names one primary endpoint, the abstract emphasizes another, the flow diagram reports a different denominator, or the statistical analysis section explains a post-hoc decision as if it were prespecified, the editor has a concrete reason to stop the manuscript before reviewer enthusiasm can help.

Reference-list and clean-citation failure mode

Editorial team at JAMA (Journal of the American Medical Association) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch

Check reference list and clean citation failure mode before submitting to JAMA →

The affected components are the reference list, introduction, discussion, guideline citations, and any systematic-review or evidence-synthesis supplement. JAMA does not need authors to cite everything. It needs the citation trail to be clean, current, and proportional to the claim. A manuscript that leans on a retracted trial, outdated guideline, uncontrolled observational paper, or specialty consensus statement without explaining the evidence hierarchy weakens the trust case even when the new study is well done.

Editorial evidence signal for JAMA (Journal of the American Medical Association)

Our review of public author guidance, recent published article packages, and Manusights pre-submission review patterns points to this practical risk: Jama editors apply practice-relevance threshold during desk-screen; mechanism-only papers without clinical-application pathway get rejected within 7 days. Treat this as a fit-and-artifact screen rather than a private outcome claim; official journal pages remain authoritative for submission mechanics and policy requirements.

Check guide build evidence signal for jama journal of the american medical association before submitting to JAMA →

For manuscripts targeting JAMA, five patterns generate the most consistent desk rejections worth knowing before submission.

Specialty paper with no visible general-medicine consequence

The JAMA instructions for authors define Original Investigations as papers whose questions matter to physicians across medicine, and the journal's 4% research acceptance rate reflects how strictly that standard is applied. Manusights pre-submission pattern analysis shows many desk rejections involve manuscripts that present strong clinical research within cardiology, oncology, neurology, or another specialty without establishing a broader clinical consequence that would matter to a general physician.

Editors specifically screen for manuscripts where the finding changes how a non-specialist physician thinks or acts, and papers that read as specialty papers with broad-significance language added consistently fail that screen.

Key Points are vague or do not commit to a practice change

The same pattern analysis often finds many submissions arrive with Key Points (Question, Findings, Meaning) that summarize the study design or findings without committing to a specific, testable practice consequence in the Meaning field. In practice, JAMA editors treat weak Key Points as a signal that the authors have not yet resolved what the paper actually says to a general-medicine reader, because the Key Points format requires a practice-facing claim, not a cautious interpretation.

Package looks operationally loose for the JAMA editorial screen

A related pattern is that many submissions arrive with one or more package elements that look incomplete or unstable: a Data Sharing Statement that describes data availability in vague terms, an EQUATOR checklist that is partially completed, a structured abstract that reads like a specialist summary rather than a practice-facing argument, or a word count that significantly exceeds the 3,000-word limit. Editors screen for operational readiness before scientific merit, and packages with visible administrative gaps are consistently returned before reaching peer review.

Practical consequence overstated beyond what the design supports

A related pattern is that many submissions frame a definitive practice recommendation from an observational design, a single-site study, or a sample size that does not visibly support the strength of the conclusion. JAMA's statistical reviewers are embedded in the editorial process, and manuscripts where the abstract or conclusion language outruns the evidence package consistently attract statistical-review flags before external peer review begins.

Cross-document mismatch between manuscript, checklist, and registry

A related pattern is that many submissions contain a mismatch between the primary endpoint stated in the manuscript and the endpoint registered in the trial registry, a CONSORT flow diagram that conflicts with numbers in the methods section, or a STROBE checklist item that references a section the manuscript does not contain. JAMA's editorial system is specifically designed to detect these mismatches, and a cross-document inconsistency is treated as a package-integrity problem rather than a revision opportunity.

SciRev community data and Clarivate JCR 2024 bibliometric data provide additional benchmarks when evaluating submission timing.

Before submitting to JAMA, a JAMA submission readiness check identifies whether your general-medicine framing, Key Points, and package completeness meet the editorial bar before you commit to the submission.

Or see example reports before you finalize.

For the broader flagship-readiness screen, use the JAMA Journal of the American Medical Association submission guide.

If the work is routed into the open-access JAMA-family path, the JAMA Network Open Under Review status guide explains how to interpret the portal, timing, and reviewer-risk work while the manuscript is in review.